| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 06/07/2005 | US6903117 Indole derivatives for the treatment of osteoporosis |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903103 Linear cyclic ureas |
| 06/07/2005 | US6903095 Phthalimido derivatives and a process for their preparation |
| 06/07/2005 | US6903079 Nucleoside compounds and compositions thereof |
| 06/07/2005 | US6902830 Organometallic complexes as phosphorescent emitters in organic LEDs |
| 06/02/2005 | WO2005051046A1 Light-emitting device, organic compound and display |
| 06/02/2005 | WO2005049736A1 Nonsolvate-form crystal of polymethine compound and process for producing the same |
| 06/02/2005 | WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 06/02/2005 | WO2005049569A1 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives |
| 06/02/2005 | WO2005049568A1 A process for industrially viable preparation of (s,s,s) phenylmethyl-2-azabicyclo-[3.3.0]-octane-3-carboxylate tosylate |
| 06/02/2005 | WO2005049567A1 A novel synthesis of 2-azabicyclic-3-carboxylic acids, useful as important drug intermediates |
| 06/02/2005 | WO2005049566A1 Processes for the preparation of n-substituted phthalimides |
| 06/02/2005 | WO2005049565A1 N-sulfonyldicarboximide containing tethering compounds |
| 06/02/2005 | WO2005049558A1 Novel prostamides for the treatment of glaucoma and related diseases |
| 06/02/2005 | WO2005049023A1 Glyt1 transporter inhibitors |
| 06/02/2005 | WO2005028445A3 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 06/02/2005 | WO2005027823A3 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
| 06/02/2005 | WO2005021504A3 New crystalline forms of carvedilol |
| 06/02/2005 | WO2004094372A3 Compounds useful as serine protease inhibitors |
| 06/02/2005 | US20050119492 Industrial scale acylation of 2-[1-(ethoxycarbonyl)butylamino]propionic acid with a carbonic acid derivative, activation with thionyl chloride, amidation with octahydroindol-2(S)-carboxylic acid, salt formation with tert-butylamine; hypotensive agents; angiotensin I-converting enzyme (ACE) inhibitor |
| 06/02/2005 | US20050119491 Copolymers with polythiophenes, polyoxadiazoles, and aromatic resins; cyclization of a 4,5,4',5'-tetrasubstituted-biphenyl-2,2'-diamine with an arylsulphonic acid; solution homopolymerization in the presence of a nickel or palladium catalyst; films for LEDs, photoelectric cells, solar cells, transistors |
| 06/02/2005 | US20050119486 Diamine derivatives |
| 06/02/2005 | US20050119342 hypercholesterolemia or hyperlipidemia; crystallization; using acetonitrile and NaOH |
| 06/02/2005 | US20050119332 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) |
| 06/02/2005 | US20050119328 Salt formimation of tegaserod and maleic acid; dissolving in acetone; precipitation |
| 06/02/2005 | US20050119327 1-benzyl-5-[(3-methylphenyl)amino]-3-phenyl-1H-indole-2-carboxylic acid; plasminogen activator inhibitor (PAI-1) inhibitor; fibrinolytic system disorder; atrial fibrillation, pulmonary and renal fibrosis, Alzheimer's disease; anticarcinogenic, antiischemic, anticoagulant, antidiabetic |
| 06/02/2005 | US20050119326 Substituted aryloximes |
| 06/02/2005 | US20050119304 N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(1H-indazol-5-yl)urea; vanilloid receptor (VR1) antagonist; blockage of neurotransmitter release |
| 06/02/2005 | US20050119268 Treatment of CRTH2-mediated diseases and conditions |
| 06/02/2005 | US20050119256 Aromatic amino acid derivates and medicinal compositions |
| 06/02/2005 | US20050119234 Cannabimimetic indole derivatives |
| 06/02/2005 | US20050118521 Charge transport monomer, charge transport material, and process for producing the same |
| 06/02/2005 | US20050118317 Novel amino acid derivative and sweetening agent |
| 06/02/2005 | DE10335545A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis |
| 06/02/2005 | CA2546815A1 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives |
| 06/02/2005 | CA2546028A1 Novel compounds |
| 06/02/2005 | CA2546024A1 Processes for the preparation of n-substituted phthalimides |
| 06/02/2005 | CA2546013A1 Novel prostamides for the treatment of glaucoma and related diseases |
| 06/01/2005 | EP1535968A2 Process for the preparation of cyanine dyes with polysulfonate anions |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534695A2 Tyrosine kinase inhibitors |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 06/01/2005 | EP1534675A1 Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo[3.1.0]hexane derivatives as muscarinic receptor antagonists |
| 06/01/2005 | EP1534671A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 06/01/2005 | EP1534666A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1534271A1 Antitumor compound and therapeutic uses thereof |
| 06/01/2005 | EP1534270A2 Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment |
| 06/01/2005 | EP1534268A2 Tyrosine kinase inhibitors |
| 06/01/2005 | EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP1058553B1 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
| 06/01/2005 | EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 06/01/2005 | EP0993441B1 INHIBITORS OF p38 |
| 06/01/2005 | EP0946499B1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/01/2005 | EP0937715B1 Tetrahydrobenzindole compounds |
| 06/01/2005 | CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 06/01/2005 | CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 06/01/2005 | CN1622937A Process for the manufacture of HMG-coa reductase inhibitors |
| 06/01/2005 | CN1622936A Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
| 05/31/2005 | US6900335 Process for producing 5-fluorooxindole and for producing intermediates therefor |
| 05/31/2005 | US6900328 Stabilizer for polymers; photostability, oxidation resistance |
| 05/31/2005 | US6900322 Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 05/31/2005 | US6900278 Ligands, complex compounds and their use for polymerising olefins |
| 05/31/2005 | US6900237 Sulfonamide compounds as protease inhibitors |
| 05/31/2005 | US6900236 Cannabimimetic indole derivatives |
| 05/31/2005 | US6900206 For therapy of HIV (human immunodeficiency virus-1) infectio and AIDS (acquired immunodeficiency syndrome) |
| 05/31/2005 | US6900194 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
| 05/31/2005 | US6900180 Mixture of folic acid, vitamin b6 and b12 with carbohydrates, fats and proteins; infant formula; sleep disorders |
| 05/31/2005 | US6899984 Linked dihydrazone-based charge transport compounds |
| 05/26/2005 | WO2005047899A2 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 05/26/2005 | WO2005047252A1 Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands |
| 05/26/2005 | WO2005047240A1 Ortho-substituted pentafluoride sulfanyl-benzenes, method for the production thereof and the use thereof in the form of valuable synthesis intermediate stages |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | US20050113583 Process for preparing glycidylphthalimide |
| 05/26/2005 | US20050113576 especially isoquinolines 5-substituted with urea, carboxamide or carbamate groups, e.g., N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; useful for treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity |
| 05/26/2005 | US20050113546 Process for the preparation of cyanine dyes with polysulfonate anions |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113440 Compounds that modulate PPAR activity and methods for their preparation |
| 05/26/2005 | US20050113439 Substituted pyrrole-indoles |
| 05/26/2005 | US20050113438 Indolecarboxylic acid derivatives as plasminogen activator inhibitor inhibitors; anticoagulant, antiischemic, and anticarcinogenic agents; noninsulin-dependent diabetes, polycystic ovarian syndrome, cardiovascular disorders, atherosclerosis, alzheimer*s disease, chronic obstructive pulmonary disease |
| 05/26/2005 | US20050113437 Preparation of 3-azabicyclo [3.1.0] hexane derivatives |
| 05/26/2005 | US20050113436 9-(4-Methylbenzyl)-6-[4-(trifluoromethoxy)phenyl]-1,9-dihydropyrano[3,4-b]indole-3,4-dione; treating fibrinolytic disorders, vein thrombosis and coronary heart disease, and pulmonary fibrosis |
| 05/26/2005 | US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 05/26/2005 | US20050113361 Amide derivatives as NMDA receptor antagonists |
| 05/26/2005 | US20050113360 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/26/2005 | US20050113359 NMDA (N-methyl-D-aspartate) receptors; eg 1-[4-(4-fluoro-benzyl)-piperidin-1-yl]-1-(6-hydroxy-1H-indole-2-yl)methanone |
| 05/26/2005 | US20050113356 Inhibitors of cathepsin S |
| 05/26/2005 | US20050112490 Electrophotographic organophotoreceptors with novel charge transport compounds |
| 05/26/2005 | US20050112487 electroconductive supports having layers containing azo compounds, charge transporting substance, acceptors and phenolic compounds, used in laser printer as well as high speed copiers |
| 05/26/2005 | CA2545452A1 Ortho-substituted pentafluoride sulfanyl-benzenes, method for the production thereof and the use thereof in the form of valuable synthesis intermediate stages |
| 05/26/2005 | CA2544983A1 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 05/26/2005 | CA2543627A1 Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/25/2005 | EP1533300A1 Organic amine salts of glutamic acid derivatives and their application |
| 05/25/2005 | EP1533299A1 Indole derivatives and drugs containing the same |
| 05/25/2005 | EP1533294A1 Beta-alanine derivative and use thereof |
| 05/25/2005 | EP1532209A2 Charge transport compositions and electronic devices made with such compositions |